ClearVision Equity Partners
Overview
ClearVision Equity is a Venture Capital firm that provides flexible growth capital and sophisticated resources to small growing companies . The firm was founded by Mitch Patridge, a successful San Diego serial entrepreneur and investor . ClearVision Equity focuses on early-stage investments, ranging from Seed to Series C .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cloudbeds | Jun 2017 | Series B | - |
| Welby Health | Jul 2025 | VC Round | Co-investor |
| Tourmaline Labs, Inc. | Sep 2018 | Seed | Lead |
| Concert Health | Jan 2021 | Series A | - |
For institutional investors. Book with your work email.
Key People
Mitch Patridge
Founder & Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ClearVision Equity Partners based?
ClearVision Equity Partners is headquartered in Dover, Delaware, United States.
When was ClearVision Equity Partners founded?
ClearVision Equity Partners was founded in 2017.
How many portfolio companies does ClearVision Equity Partners have?
ClearVision Equity Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in ClearVision Equity Partners's portfolio?
Portfolio companies visible on Caplight include Cloudbeds, Welby Health, Tourmaline Labs, Inc., Concert Health.
What was ClearVision Equity Partners's most recent investment shown here?
ClearVision Equity Partners's most recent investment in this portfolio sample was in Welby Health in 2025.
What sectors does ClearVision Equity Partners focus on?
ClearVision Equity Partners focuses on Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Mobility, Transportation & Logistics, Enterprise Software, Real Estate & PropTech, Enterprise Software.
What company stages does ClearVision Equity Partners focus on?
Stage focus information for ClearVision Equity Partners is not publicly available.
What is ClearVision Equity Partners's AUM?
ClearVision Equity Partners's assets under management are estimated between $0.0 and $50.0M.